Viewing StudyNCT00399945



Ignite Creation Date: 2024-05-05 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00399945
Status: COMPLETED
Last Update Posted: 2007-05-07
First Post: 2006-11-14

Brief Title: Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer Scintigraphy Study
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Cystic Fibrosis
Keywords:
Name View
Cystic fibrosis tobramycin PARI eFlow PARI LC Plus nebulizer pharmacoscintigraphy View